ZVRA Competitors & Alternatives
Compare Zevra Therapeutics Inc. with similar stocks in the same industry
Biotechnology
ZVRA
Main Stock$9.99
Tradestie Score
47
Market Cap
$529.35M
P/E Ratio
10.9
Revenue Growth
0.5%
Analyst Upside
+150.3%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$10.79
|
$665.30M | 13.0 | 63 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.74
|
$626.91M | - | 67 | Compare |
|
SVRA
Savara Inc.
|
$4.81
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.56
|
$552.46M | - | 46 | Compare |
|
VSTM
Verastem, Inc.
|
$7.70
|
$541.60M | - | 54 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.90
|
$540.97M | - | 47 | Compare |
|
MPLT
MPLT
|
$9.82
|
$535.19M | - | 47 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$77.97
|
$522.78M | - | 57 | Compare |
More ZVRA Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry